Diabetes diagnosis based on glucose control levels and time until diagnosis: a regression discontinuity approach to assess the effect on direct healthcare costs

Table 1 Descriptive statistics on sociodemographic characteristics and health status for the whole sample

	Whole sample N = 285,450
Gender: female (%)	45.75
Age	66.86 (12.48)
Drug co-payment level indicator, %
Exempted	5.04
10% co-payment	69.44
40% co-payment	16.88
50% co-payment	7.66
60% co-payment	0.47
Excluded from co-payment	0.51
Country or geographical are of birth, %
Spain	92.62
Magreb	2.01
South America	1.14
Eastern Europe	0.77
Others	3.46
Individual health status, AMG	335.27 (20.57)
Comorbidities, %
Hypertension	63.84
Overweight	46.55
Weight loss	1.38
Myocardial infarction	8.37
Congestive heart failure	4.42
Other heart failure	0.52
Peripheral vascular disease	5.28
Stroke	4.51
Other cerebrovascular diseases	5.51
Other cardiovascular diseases	8.72
Neuropathy	3.31
Retinopathy	9.51
Other vascular diseases	0.19
Dementia	1.74
Renal failure	19.11
Severity according to comorbidities prevalence, %
Mild	72.46
Moderate	5.50
Severe	22.04

Note Means are presented as its mean value, with the standard deviation within brackets unless indicated otherwise. AMG stands for Adjusted Morbidity Group

ISSN: 2191-1991